353 related articles for article (PubMed ID: 27164323)
1. Herpes zoster and the search for an effective vaccine.
Arnold N; Messaoudi I
Clin Exp Immunol; 2017 Jan; 187(1):82-92. PubMed ID: 27164323
[TBL] [Abstract][Full Text] [Related]
2. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
3. CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.
Haberthur K; Engelmann F; Park B; Barron A; Legasse A; Dewane J; Fischer M; Kerns A; Brown M; Messaoudi I
PLoS Pathog; 2011 Nov; 7(11):e1002367. PubMed ID: 22102814
[TBL] [Abstract][Full Text] [Related]
4. [Vaccines against varicella-zoster virus (VZV)].
Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for varicella-zoster virus infections.
Andrei G; Snoeck R
Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
[TBL] [Abstract][Full Text] [Related]
6. Prevention of shingles by varicella zoster virus vaccination.
Holodniy M
Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
[TBL] [Abstract][Full Text] [Related]
7. The effect of vaccination on the epidemiology of varicella zoster virus.
Edmunds WJ; Brisson M
J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
[TBL] [Abstract][Full Text] [Related]
8. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults.
Sanford M; Keating GM
Drugs Aging; 2010 Feb; 27(2):159-76. PubMed ID: 20104941
[TBL] [Abstract][Full Text] [Related]
9. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Oxman MN; Levin MJ; Johnson GR; Schmader KE; Straus SE; Gelb LD; Arbeit RD; Simberkoff MS; Gershon AA; Davis LE; Weinberg A; Boardman KD; Williams HM; Zhang JH; Peduzzi PN; Beisel CE; Morrison VA; Guatelli JC; Brooks PA; Kauffman CA; Pachucki CT; Neuzil KM; Betts RF; Wright PF; Griffin MR; Brunell P; Soto NE; Marques AR; Keay SK; Goodman RP; Cotton DJ; Gnann JW; Loutit J; Holodniy M; Keitel WA; Crawford GE; Yeh SS; Lobo Z; Toney JF; Greenberg RN; Keller PM; Harbecke R; Hayward AR; Irwin MR; Kyriakides TC; Chan CY; Chan IS; Wang WW; Annunziato PW; Silber JL;
N Engl J Med; 2005 Jun; 352(22):2271-84. PubMed ID: 15930418
[TBL] [Abstract][Full Text] [Related]
10. Varicella zoster virus vaccines: potential complications and possible improvements.
Silver B; Zhu H
Virol Sin; 2014 Oct; 29(5):265-73. PubMed ID: 25358998
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
[TBL] [Abstract][Full Text] [Related]
12. Varicella zoster virus vaccines: effective, but concerns linger.
Liesegang TJ
Can J Ophthalmol; 2009 Aug; 44(4):379-84. PubMed ID: 19606157
[TBL] [Abstract][Full Text] [Related]
13. Molecular studies of the Oka varicella vaccine.
Quinlivan M; Breuer J; Schmid DS
Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
[TBL] [Abstract][Full Text] [Related]
14. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
[TBL] [Abstract][Full Text] [Related]
15. Varicella zoster virus infection.
Gershon AA; Breuer J; Cohen JI; Cohrs RJ; Gershon MD; Gilden D; Grose C; Hambleton S; Kennedy PG; Oxman MN; Seward JF; Yamanishi K
Nat Rev Dis Primers; 2015 Jul; 1():15016. PubMed ID: 27188665
[TBL] [Abstract][Full Text] [Related]
16. Immune Responses to Varicella-Zoster Virus Vaccines.
Levin MJ; Weinberg A
Curr Top Microbiol Immunol; 2023; 438():223-246. PubMed ID: 35102438
[TBL] [Abstract][Full Text] [Related]
17. Varicella and herpes zoster vaccine development: lessons learned.
Warren-Gash C; Forbes H; Breuer J
Expert Rev Vaccines; 2017 Dec; 16(12):1191-1201. PubMed ID: 29047317
[TBL] [Abstract][Full Text] [Related]
18. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
[TBL] [Abstract][Full Text] [Related]
19. Strategies for herpes zoster vaccination of immunocompromised patients.
Cohen JI
J Infect Dis; 2008 Mar; 197 Suppl 2(Suppl 2):S237-41. PubMed ID: 18419403
[TBL] [Abstract][Full Text] [Related]
20. Varicella-zoster virus.
Arvin AM
Clin Microbiol Rev; 1996 Jul; 9(3):361-81. PubMed ID: 8809466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
